P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...
Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...
A recent study found that more than half of people with chronic urticaria experience a significant impact on their work. Share on Facebook. Opens in a new tab or window Share on X. Opens in a new ...
Adam Friedman, MD: Hello, and welcome to Medscape Care Cues. I'm Dr Adam Friedman and I'm joined by my good friend and colleague, Dr Shawn Kwatra. Welcome, Shawn. Shawn G. Kwatra, MD: Thanks so ...
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profileMean change in UAS7 ...
Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...
Please provide your email address to receive an email when new articles are posted on . Researchers reported improvements at 1 month in OSDI scores, corneal fluorescein staining, and conjunctival ...
Analyst Etzer Darout from BMO Capital reiterated a Buy rating on Jasper Therapeutics (JSPR – Research Report) and keeping the price target at ...
Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified. Data on ...
Participants’ body fat levels did not significantly influence this outcome, indicating that a healthy diet may directly and independently aid in managing chronic pain. Experts recommend adding ...
How would you manage her leg symptoms? Chronic venous insufficiency manifests as a spectrum of signs and symptoms, including varicose veins, leg swelling, skin changes, and leg ulcers. The ...
Novartis' big-selling IgE inhibitor Xolair has been a mainstay of treatment for refractory chronic spontaneous urticaria (CSU) for many years, but its efforts to find a successor have seen some ...